EP1385986A2 - Ensemble biopuce - Google Patents

Ensemble biopuce

Info

Publication number
EP1385986A2
EP1385986A2 EP02740338A EP02740338A EP1385986A2 EP 1385986 A2 EP1385986 A2 EP 1385986A2 EP 02740338 A EP02740338 A EP 02740338A EP 02740338 A EP02740338 A EP 02740338A EP 1385986 A2 EP1385986 A2 EP 1385986A2
Authority
EP
European Patent Office
Prior art keywords
permeation layer
biochip arrangement
arrangement according
substrate
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02740338A
Other languages
German (de)
English (en)
Inventor
Alexander Frey
Franz Hofmann
Richard Johannes Luyken
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Infineon Technologies AG
Original Assignee
Infineon Technologies AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infineon Technologies AG filed Critical Infineon Technologies AG
Publication of EP1385986A2 publication Critical patent/EP1385986A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438—Electrodes

Definitions

  • the invention relates to a biochip arrangement.
  • Bio and genetic engineering has become increasingly important in recent years.
  • a basic technique in biotechnology and genetic engineering is to be able to detect biological molecules such as DNA (deoxyribonucleic acid) or RNA, proteins, polypeptides, etc.
  • bio-molecules in which genetic information is coded in particular DNA molecules (deoxyribonucleic acid) are of great interest for many medical applications.
  • a DNA is a double helix that is made up of two cross-linked helical single chains, so-called half-strands. Each of these half-strands has a base sequence, the genetic information being determined by the sequence of the bases (adenine, guanine, thymine, cytosine). DNA half-strands have the characteristic property of being very specific in binding only to very specific other molecules. It is therefore a prerequisite for docking a strand of nucleic acid to another strand of nucleic acid that the two molecules are complementary to one another. The two molecules must clearly fit together like a key and the matching lock (so-called key-lock principle).
  • catcher molecules for example by means of microdispensing
  • catcher molecules are first applied and immobilized on a substrate made of a suitable material, ie are permanently fixed to the surface of the biochip sensor.
  • catcher molecules for example by means of microdispensing
  • Such a biochip sensor with a substrate with capture molecules bound to it, which are sensitive, for example, to a specific DNA half-strand to be detected, is usually used to examine a liquid for the presence of the DNA half-strand sensitive to the capture molecules.
  • the liquid to be examined for the presence of a specific DNA half-strand must be brought into active contact with the immobilized capture molecules. If a catcher molecule and a DNA half strand to be examined are complementary to one another, the DNA semiconductor strand hybridizes to the catcher molecule, i.e. he is bound to it.
  • the value of a physical quantity which can be measured by measurement changes in a characteristic manner, the value of this quantity can be measured and the presence or absence of a DNA half-strand in a liquid to be examined can be detected in this way.
  • nucleic acids can be used as capture molecules for peptides or proteins that bind specifically to nucleic acids. It is also known to use peptides or proteins as capture molecules for other proteins or peptides that bind the capture peptide or capture protein. Also of importance is the use of low molecular weight chemical compounds as capture molecules for proteins or peptides that bind to these low molecular weight compounds. Low molecular weight chemical compounds are those chemical compounds that are less than about 1700 daltons (molecular weight in grams per mole). Conversely, the use of proteins and peptides as capture molecules for low-molecular compounds which may be present in a liquid to be examined is also possible.
  • Electronic detection methods are often used to detect the binding that has occurred between the capture molecule applied to the substrate and the molecule to be detected that is present in the liquid to be examined. Such detection methods are becoming increasingly popular
  • the biochip arrangement 100 has a substrate 101, in the surface area of which a first electrode 102 and a second electrode 103 are arranged.
  • the first electrode 102 is coupled to a first electrical contact 104.
  • the second electrode 103 is coupled to a second electrical contact 105, an electrical signal being removable between the first electrical contact 104 and the second electrical contact 105.
  • Electrode 103 has a large number of capture molecules 106 immobilized. Frequently, the first electrode 102 and the second electrode 103 are made of a gold material, and the immobilization of the capture molecules 106 on the first and the second electrode 102, 103 is often realized as a gold-sulfur coupling. Many bio-molecules have sulfur atoms in their end sections, for example so-called thiol Groups (SH groups): The gold-sulfur material pair has particularly favorable coupling properties. 1A also shows an electrolytic liquid 107 to be examined, which possibly has DNA half-strands 108 complementary to the catcher molecules 106.
  • SH groups thiol Groups
  • the catcher molecules 106 according to the key-lock principle (according to which only those molecules in the liquid 107 to be examined can be bound by the catcher molecules 106 for which the latter have a sufficient binding specificity) with a molecule present in the liquid to be examined 107 enter into a specific binding reaction, the molecule (for example a DNA half-strand 108) is specifically bound in the liquid 107 to be examined by the capture molecules 106. If this is not the case, then the molecule in the liquid 107 to be examined is not bound by one of the capture molecules 106.
  • DNA strands 108 are contained in the electrolytic liquid to be examined 107 DNA strands 108 with a base sequence that corresponds to the base sequence of the
  • Capture molecules 106 i.e. the DNA probe molecules
  • these DNA half strands 108 hybridize with the DNA probe molecules 106. This is shown in Fig. 1B.
  • Hybridization of a DNA probe molecule 106 with a DNA half strand 108 only takes place if the base sequences of the respective DNA probe molecule 106 and the matching DNA half strand 108 are complementary to one another. If this is not the case, no hybridization takes place.
  • a DNA probe molecule 106 of a given base sequence is only able to bind very specific, namely DNA half-strands with a complementary base sequence, ie to hybridize with it.
  • Hybridization refers to the binding of DNA half-strands to capture molecules.
  • a successful hybridization of DNA half strands 108 to catcher molecules 106 has a characteristic influence on an electrical signal that can be removed between the first electrical contact 104 and the second electrical contact 105.
  • the DNA half-strands 108 and the capture molecules 106 are largely electrically non-conductive and clearly shield the first electrode 102 and the second electrode 103 electrically. This changes the capacitance between the first electrode 102 and the second electrode 103. The change in the capacitance is used as a measurement variable for the detection of DNA molecules. If there are molecules to be detected in the liquid to be examined and these have hybridized with the catcher molecules on the surface of the electrodes, the value of the capacitance of the electrodes 102, 103 that can be interpreted as capacitor areas can be measured.
  • FIG. 2A shows a top view of a biochip arrangement 200 with interdigital electrodes 202, 203. Furthermore, FIG. 2B shows a cross section of the biochip arrangement 200 shown in FIG. 2A along the line I-I '.
  • the biochip arrangement 200 has a substrate 201, a first interdigital electrode 202 and a second interdigital electrode 203.
  • the first and second interdigital electrodes 202, 203 shown in FIGS. 2A, 2B form an approximately meandering surface structure on the substrate.
  • the described biochip arrangements according to the prior art have a number of disadvantages.
  • Biological molecules such as DNA strands or proteins are often present in very low concentrations (millimolar, sometimes even only micromolar). Therefore, the response time of the DNA sensors shown in FIGS. 1A, 1B, 2A, 2B is very high.
  • Response time is understood to be a characteristic time that must be waited until molecules to be detected have bound to catcher molecules in sufficient numbers and, as a result, a change in capacitance that can be verified by measurement has occurred.
  • the biochip arrangement according to the prior art can only be used to a very limited extent under practical laboratory conditions. Rapid detection of molecules is regularly sought. Bio-molecules to be detected, such as unstable mutants of proteins, often denature with time constants of a few hours and less. Hence the slow
  • the sensitivity of the biochip arrangement according to the prior art is not sufficiently high, which is also related to the low concentration of the bio-molecules to be detected in the vicinity of the electrodes provided with capture molecules.
  • a biochip arrangement is known from [1], which enables a sufficiently large number of DNA molecules to be docked onto the capture molecules in a sufficiently short time, even at low DNA concentrations. According to [1], this is achieved by a so-called
  • Permeation level is applied directly to the chip.
  • the permeation plane known from [1] has an electrically conductive layer which is surrounded by a porous protective layer. An electrical voltage can be applied to the electrically conductive layer.
  • a porous protective layer is provided around the electrically conductive core layer of the permeation layer.
  • This porous protective layer around the electrically conductive core of the permeation layer is only permeable to the ions of the electrolyte, whereas molecules above a predetermined size cannot penetrate the porous protective layer. Therefore, biological macromolecules such as DNA half-strands or proteins cannot penetrate the porous protective layer, so that the sensitive bio-molecules are protected by the porous protective layer against direct contact with the electrically conductive layer of the permeation layer. The bio-molecules are therefore protected from decomposition.
  • Permeation level directly on the chip is technologically difficult and complex. To ensure their intended function, a sufficiently large area of the chip must be provided with the permeation layer. This space requirement is at the expense of the interdigital electrodes.
  • the provision of the permeation layer on the chip therefore reduces the active sensor area available for the interdigital electrodes.
  • the active surface on which capture molecules can be immobilized is therefore reduced by the presence of the permeation layer. This is associated with a loss of detection sensitivity. This increases the response time that must be waited for until the molecules to be detected hybridize with the capture molecules.
  • [3] also describes a method for carrying out reactions between at least two reaction partners, in particular bio-molecules, in which at least one bio-molecule passes through reaction areas with different reaction conditions and at least one
  • Reaction partner for example a feature of a bio-chip, is immobilized, and in which the reaction mixtures are moved hydrodynamically.
  • the invention is based on the problem of providing a biochip arrangement with an increased detection sensitivity.
  • the biochip arrangement of the invention has a substrate, at least one sensor arranged on or in the substrate, and an electrically conductive permeation layer, which is arranged at a predetermined, non-zero distance from the surface of the substrate, and to which an electrical voltage - can be created.
  • the biochip arrangement of the invention it is possible to provide the entire surface of the substrate with sensors, which with is accompanied by increased sensitivity to detection.
  • the active area on the substrate is increased compared to the prior art. This makes it possible according to the invention to detect even lower concentrations of bio-molecules or to reduce the detection time.
  • the biochip arrangement also has a spacer which is arranged between the substrate and the permeation layer and whose thickness is equal to the predetermined distance of the permeation layer from the surface of the substrate.
  • the spacer Due to the thickness of the spacer, the distance between the permeation layer and the surface of the substrate can therefore be precisely predetermined, the spacer preferably having a thickness between approximately 1 ⁇ m and approximately 2 ⁇ m.
  • the thickness of the spacer can be flexibly adjusted to the needs of the individual case.
  • the spacer is made of any inexpensive
  • the biochip arrangement can furthermore have a limiting device, the limiting device being arranged along a closed path on the permeation layer in such a way that a cavity is formed by the limiting device and the permeation layer.
  • a cavity to be examined can be conveniently filled in the permeation layer.
  • the dimensions of the limiting device can be flexibly adjusted to the volumes of a liquid to be examined that are available in the individual case.
  • DNA strands can be decomposed if they come into direct contact with a metallic electrode, if there are free electrical charges on this metallic electrode. For this reason, the core of the permeation layer made of an electrically conductive material is surrounded by a shell made of a porous material.
  • the porous material of the permeation layer has pores of a predeterminable size such that molecules whose size is smaller than or equal to the predetermined pore size can diffuse through the porous material, whereas molecules whose size exceeds the predetermined pore size do not diffuse through the porous material can. This makes it usually the smallest in volume
  • Permeation layer defined cavity to fill the liquid to be examined. Now an electrical between the permeation layer and the reference electrode
  • the permeation layer is at an electrically positive potential, it is usually negatively charged DNA half strands are electrically attracted to the permeation layer. This increases the concentration of the DNA half-strands in an environment of the permeation layer in comparison to the average concentration of the DNA half-strands in the filled liquid.
  • the at least one sensor on the surface of the substrate is arranged at a distance from the permeation layer that is adjustable from zero but is sufficiently small. The increase in concentration of the detected
  • Molecules reach a maximum near the permeation layer and decrease with increasing distance from the permeation layer. The smaller the distance is set, the stronger the increase in concentration caused by the permeation layer also has on the concentration of the bio-molecules on the active sensor surface. Therefore, according to the invention, the concentration of the bio-molecules to be detected is also increased in a direct environment of the sensors. This increase in the concentration of the bio-molecules to be detected is accompanied by an increase in the sensitivity of detection or a reduction in the characteristic response time required for hybridization.
  • the biochip arrangement of the invention has a very simple structure, so that the production is cheap and not very time-consuming.
  • the permeation layer of the biochip arrangement is set up in such a way that the bio-molecules can penetrate it. According to the invention, this is necessary in order to bring the molecules to be detected into direct operative contact with the capture molecules arranged on the surface of the sensors.
  • This can be achieved by designing the permeation layer of the invention as a grid.
  • a grid consists of wires stretched in two mutually orthogonal directions. The meshes defined by these wires OJ OJ tsJ t t- 1
  • the contact plane is the surface of the substrate that is provided with at least one sensor.
  • a sensor can be designed as a gold electrode with capture molecules immobilized thereon.
  • the thickness of the polyimide ring is, for example, 1 ⁇ m to 2 ⁇ m.
  • Maximum stability of the permeation network which is formed on the polyimide ring can be achieved by providing additional spacers as support points made of polyimide.
  • a plexiglass tube is used as the limiting device.
  • the plexiglass tube can be glued to the permeation network, and this plexiglass tube glued to the permeation network can be pressed onto and glued to the polyimide ring.
  • the polyimide ring is attached to the surface of the substrate, for example glued.
  • the permeation network is very close to the contact level of the capture molecules. If an electrical voltage of a suitable sign is now applied between the permeation network and a reference electrode, the result is that the concentration of DNA half-strands contained in the liquid to be examined increases in the vicinity of the permeation plane as a result of electrophoresis.
  • FIG. 1A shows a cross-sectional view of a biochip arrangement according to the prior art
  • FIG. 1B shows another cross-sectional view of a biochip arrangement according to the prior art
  • FIG. 2A shows a top view of a biochip arrangement with interdigital electrodes according to the prior art
  • FIG. 2B shows a cross-sectional view along a line I-I 'of the biochip arrangement shown in FIG. 2A with interdigital electrodes according to the prior art
  • FIG. 3A shows a cross-sectional view of a biochip arrangement according to a first exemplary embodiment of the invention
  • FIG. 3B shows a cross-sectional view of a biochip arrangement according to a second exemplary embodiment of the
  • FIG. 3C shows a cross-sectional view of a biochip arrangement according to a third exemplary embodiment of the invention
  • FIG. 4A shows a cross-sectional view of a biochip arrangement according to a fourth exemplary embodiment of the invention
  • FIG. 4B shows a top view of the biochip arrangement shown in FIG. 4A according to the fourth exemplary embodiment of the invention.
  • the biochip arrangement 300 has a substrate 301, at least one sensor 302 arranged on or in the substrate 301 and an electrically conductive permeation layer 303, which is spaced at a predetermined distance other than zero (this distance is symbolized in FIG. 3A with a double arrow) marked "d") from the surface of the substrate 301 J OJ K t- 1 H »
  • the limiting device 305 may alternatively be made from another suitable material. Since a cavity is formed by the permeation layer 303 and the limiting device 305, a liquid to be examined can be filled into this cavity.
  • the liquid to be examined can be filled into the cavity with a cannula or a pipette.
  • the limiting device 305 also has a characteristic height. By suitably selecting this height of the limiting device 305, the biochip arrangement 310 can be flexibly adjusted to the needs of the individual case. Biological samples to be examined with a biochip arrangement 310 are often present in only small volumes.
  • the limiting device 305 can be selected with a suitable height in accordance with a predetermined volume of a liquid to be examined.
  • the limiting device 305 is attached to the permeation layer 303 by being glued to the permeation layer 303.
  • 3C shows a biochip arrangement 320 according to a further exemplary embodiment of the invention.
  • the at least one sensor 302 from FIGS. 3A, 3B has at least one electrode 306, wherein each electrode 306 can be coupled to electrical contacts 307, 308.
  • each of the electrodes 306 is coupled to a first electrical contact 307 or to a second electrical contact 308.
  • a signal can be removed between the first electrical contact 307 and the second electrical contact 308.
  • this signal is detected by a means for detecting an electrical signal 309.
  • the means for detecting an electrical signal 309 can be a voltmeter.
  • the biochip arrangement 320 also has a multiplicity of Capture molecules 311, which are coupled to the electrodes 306.
  • the biochip arrangement of FIG. 3C has a reference electrode 312. Between the
  • FIG. 3C schematically shows an electrolytic liquid 314 to be examined, which can be examined by means of the biochip arrangement 320 for the presence of a specific bio-molecule, for example a specific DNA half-strand.
  • Bio-molecules to be detected may be contained in the liquid 314 to be examined (not shown in FIG. 3C). Furthermore, by means of a filling device (in
  • a liquid 314 to be examined can be filled into the biochip arrangement 320.
  • a filling device can be, for example, a pipette or a cannula.
  • a further spacer 315 is shown in FIG. 3C. Like the spacer 304, this is arranged between the substrate 301 and the permeation layer 303. The thickness of the further spacer 315 is equal to the predetermined distance of the permeation layer 303 from the
  • the spacer 304 primarily fulfills two functions. On the one hand, the spacer 304 maintains the distance, which can be predetermined by its thickness, between the substrate 301 and the permeation layer 303. In addition, the spacer 304 serves to mechanically stabilize the permeation layer 303 along the circumference of the, for example, essentially circular permeation layer 303. If the spacer 304 is essentially ring-shaped or hollow-cylindrical, this may not be sufficient in a central section of the permeation layer 303 mechanically stabilized be. For this purpose, according to the exemplary embodiment shown in FIG.
  • the further spacer 315 is provided, which stabilizes the essentially circular permeation layer 303 in a central section.
  • a plurality of further spacers 315 can also be provided in order to mechanically stabilize the permeation layer 303 at further points.
  • the at least one further spacer 315 can also serve to maintain the constant one in a central section of the permeation layer 303
  • the at least one further spacer 315 can maintain the essentially planar structure of the permeation layer 303.
  • the permeation layer 303 shown in FIG. 3C has a core that is made of an electrically conductive material.
  • the permeation layer 303 also has a shell surrounding the core, which is made of a porous material.
  • the porous material of the permeation layer 303 has pores of a predetermined size such that molecules whose size is less than or equal to the predetermined pore size can diffuse through the porous material, whereas molecules whose size exceeds the predetermined pore size cannot through the porous material. Can diffuse material through.
  • the core of the permeation layer 303 which is made of an electrically conductive material, is porous Protective layer.
  • This protective layer can be penetrated by small molecules and ions, whereas it cannot be penetrated by large molecules such as the sensitive bio-molecules to be examined.
  • the pore size can be adjusted, it can be determined which molecules can diffuse through the porous protective layer and which cannot.
  • the electrically conductive material of the permeation layer 303 is preferably a metal or a semiconductor. However, it can also be any other conductive material, for example electrically conductive polymers.
  • the electrically conductive material of the permeation layer 303 is preferably gold material.
  • the permeation layer 303 is configured as a grid.
  • a grid network is formed from electrically conductive wires which are tensioned in parallel in two mutually orthogonal directions and are encased in a porous material.
  • the wires of the grid which are arranged, for example, at a distance of approximately 100 nm from one another, form meshes whose dimension is preset such that the meshes of the bio-molecules to be detected, which may be contained in the liquid 314 to be examined, due to their size can be penetrated.
  • the bio-molecules are detected by binding to the
  • the functionality of the biochip arrangement 320 requires that an electrical voltage 313 is applied between the permeation layer 303 and the reference electrode 312. If the electrical voltage 313 is selected such that the permeation layer is charged positively as a result of the electrical voltage, then electrically negatively charged, to be detected bio-molecules contained in the liquid 314 to be detected are attracted by the permeation layer 303 by an electrical force and therefore move towards the permeation layer 303 (electrophoresis). For example, DNA half strands below physiological pH values (approximately pH 6 to pH 9) are electrically negatively charged in solution. A permeation layer 303 which is at a positive electrical voltage is therefore suitable for accumulating negatively charged DNA half-strands in the vicinity of the permeation layer 303. Due to the increase in the concentration of the molecules to be detected in the vicinity of the permeation layer 303 or in the vicinity of the capture molecules 311
  • an electrical voltage 313 is applied between the reference electrode 312 and the permeation layer 303 so that the permeation layer 303 is negatively charged, electrically positively charged bio-molecules become in the vicinity of the permeation layer 303 as a result of electrophoresis gather.
  • proteins at physiological pH values are often electrically positively charged.
  • Liquid 314 possibly contained bio-molecules is made by binding the bio-molecules to the LO OJ t 1 H "
  • a liquid to be examined can be filled into the cavity which is formed by the permeation network 403 and the limiting device 405.
  • An electrical voltage can be applied between the permeation network 403 and the reference electrode 410, on the basis of which, as a result of electrophoresis, the bio-molecules to be detected, which may be present in the liquid to be examined, accumulate in a surrounding area of the permeation network 403.
  • the spacer 404 sets a distance, which can be predetermined by its thickness, between the permeation network 403 and the active sensor plane, that is to say the surface of the substrate 401, on or in which the sensors 402 are arranged. This distance is preferably 1 to 2 ⁇ m.
  • each of the sensors 402 In order to operate the biochip arrangement 400 shown in FIGS. 4A and 4B as a DNA sensor, each of the sensors 402 must be selected as an electrically conductive electrode with suitable capture molecules immobilized thereon (not shown in FIGS. 4A, 4B) ). The one to be examined
  • Liquid including the biological macromolecules penetrates the mesh 411 of the permeation network 403 (see FIG. 4B).
  • the bio-molecules to be detected for example DNA half-strands, come into active connection with the capture molecules on the surface of the electrodes. If the bio-molecules to be detected and the capture molecules immobilized on the surface of the electrodes are complementary to each other, hybridization takes place.
  • the electrical parameter capacitance changes between the sensors 402 provided as electrodes. The capacitance or any other parameter can be changed between the first electrical contact 407 and the second electrical contact 408 are detected.
  • the electrical coupling between the first electrical contact 407 or the second electrical contact 408 and the sensors 402 is realized by electrical connecting means 409. Like the sensors 402 or the electrical contacts 407, 408, these can be integrated on the substrate 401 (for example a silicon wafer) or can be provided as separate electrical components.
  • the spacer 404 is attached directly to the surface of the substrate 401.
  • the spacer 404 can, for example, on the surface of the
  • Substrate 401 be glued, alternatively, the
  • Spacers 404 also by means of a semiconductor technology process on the surface of the
  • Substrate 401 be deposited.
  • the spacer 404 is implemented as a polyimide ring.
  • the thickness of this polyimide ring is preferably 1 to 2 ⁇ m.
  • Permeation network 403 attached, for example glued.
  • the permeation network according to the preferred exemplary embodiment is designed as a network of wires stretched parallel to one another and arranged in two directions perpendicular to one another, as a result of which meshes 411 are formed.
  • the limiting device 405 is in accordance with the in FIG. 4A, FIG.
  • FIG. 4B shown embodiment of the biochip arrangement 400 according to the invention formed as a plexiglass tube, which is glued to the surface of the permeation network 403, for example.
  • both the Spacer 404 as well as the limiting device 405 according to the described exemplary embodiment of the biochip arrangement 400 are provided essentially in the form of a hollow cylinder.
  • Filling device 406 a liquid to be examined, usually in the milliliter to microliter range, can be filled into the biochip arrangement 400.
  • the filling device 406 can be a pipette or a cannula, for example.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Ensemble biopuce qui possède un substrat, au moins un capteur placé sur ou dans ledit substrat et une couche de perméation électro-conductrice placée à un écart prédéterminé et différent de zéro de la surface du substrat et à laquelle peut être appliquée une tension électrique. Ledit ensemble biopuce peut par exemple être utilisé comme capteur d'ADN du fait que des molécules d'accrochage immobilisées sur des électrodes de capteur s'hybrident avec des molécules d'ADN, un signal électrique de capteur qui peut être prélevé entre des électrodes de capteur étant ainsi influencé de manière caractéristique.
EP02740338A 2001-05-10 2002-05-10 Ensemble biopuce Withdrawn EP1385986A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10122659 2001-05-10
DE10122659A DE10122659A1 (de) 2001-05-10 2001-05-10 Biochip-Anordnung
PCT/DE2002/001700 WO2002090573A2 (fr) 2001-05-10 2002-05-10 Ensemble biopuce

Publications (1)

Publication Number Publication Date
EP1385986A2 true EP1385986A2 (fr) 2004-02-04

Family

ID=7684251

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02740338A Withdrawn EP1385986A2 (fr) 2001-05-10 2002-05-10 Ensemble biopuce

Country Status (4)

Country Link
US (1) US20040219547A1 (fr)
EP (1) EP1385986A2 (fr)
DE (1) DE10122659A1 (fr)
WO (1) WO2002090573A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10145701A1 (de) * 2001-09-17 2003-04-10 Infineon Technologies Ag Fluoreszenz-Biosensorchip und Fluoreszenz-Biosensorchip-Anordnung
DE10224567B4 (de) * 2002-06-03 2014-10-23 Boehringer Ingelheim Vetmedica Gmbh Sensor-Anordnung und Verfahren zum Betreiben einer Sensor-Anordnung
GB0300820D0 (en) * 2003-01-14 2003-02-12 Diagnoswiss Sa Membrane-microchannel strip
DE10328136A1 (de) * 2003-06-23 2005-01-27 Infineon Technologies Ag Sensor-Element, Sensor-Array und Verfahren zum Erfassen von in einem Analyten möglicherweise enthaltenen Partikeln
FR2861609B1 (fr) 2003-10-31 2006-02-03 Commissariat Energie Atomique Procede de repartition de gouttes d'un liquide d'interet sur une surface
FR2861608B1 (fr) * 2003-10-31 2005-12-23 Commissariat Energie Atomique Dispositif de travail comportant des zones de travail bordees, laboratoire sur puce et microsysteme
US11525829B2 (en) * 2017-08-02 2022-12-13 Hemosmart Medical Technology Ltd. Method for capturing target cells or molecules in solution
CN117157383A (zh) * 2021-08-31 2023-12-01 深圳华大生命科学研究院 一种检测结构、方法、检测芯片以及传感装置

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5167820A (en) * 1986-03-24 1992-12-01 Ensci, Inc. Porous membranes and methods for using same
IL93020A (en) * 1990-01-09 1995-06-29 Yeda Res & Dev Biosensors comprising a lipid bilayer doped with ion channels anchored to a recording electrode by bridging molecules
US5776672A (en) * 1990-09-28 1998-07-07 Kabushiki Kaisha Toshiba Gene detection method
EP0639269B1 (fr) * 1991-03-27 2002-06-12 Ambri Limited Reservoir ionique agence a la surface d'une electrode
US5632957A (en) * 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
US6051380A (en) * 1993-11-01 2000-04-18 Nanogen, Inc. Methods and procedures for molecular biological analysis and diagnostics
ATE181155T1 (de) * 1993-08-13 1999-06-15 Haan Andre Herstellungsverfahren fur ein halbleiterelement und detektor mit einem solchen halbleiterelement
US6207373B1 (en) * 1998-02-25 2001-03-27 Nanogen, Inc. Methods for determining nature of repeat units in DNA
US6306348B1 (en) * 1993-11-01 2001-10-23 Nanogen, Inc. Inorganic permeation layer for micro-electric device
US6071394A (en) * 1996-09-06 2000-06-06 Nanogen, Inc. Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis
WO1996042013A1 (fr) * 1995-06-08 1996-12-27 Visible Genetics Inc. Puce de microelectrophorese pour deplacer et separer des acides nucleiques et autres molecules chargees
AUPO714897A0 (en) * 1997-06-03 1997-06-26 Australian Membrane And Biotechnology Research Institute Model membrane systems
CN1237165C (zh) * 1998-02-20 2006-01-18 内诺金有限公司 分子生物学分析和诊断用的有源装置和方法
US6251343B1 (en) * 1998-02-24 2001-06-26 Caliper Technologies Corp. Microfluidic devices and systems incorporating cover layers
DE19980632B4 (de) * 1998-04-08 2005-07-07 Universität Heidelberg Verfahren zur Durchführung von Reaktionen zwischen mindestens zwei Reaktionspartnern in wässrigen Reaktionsgemischen
US6090572A (en) * 1998-06-26 2000-07-18 Biostar, Incorporated Filtration and extraction device and method of using the same
US6303082B1 (en) * 1999-12-15 2001-10-16 Nanogen, Inc. Permeation layer attachment chemistry and method
JP3757412B2 (ja) * 2000-02-22 2006-03-22 横河電機株式会社 バイオチップ

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO02090573A2 *

Also Published As

Publication number Publication date
DE10122659A1 (de) 2002-12-05
WO2002090573A3 (fr) 2003-04-10
WO2002090573A2 (fr) 2002-11-14
US20040219547A1 (en) 2004-11-04

Similar Documents

Publication Publication Date Title
DE19860547C1 (de) Affinitätssensor für den Nachweis spezifischer molekularer Bindungsereignisse und dessen Verwendung
DE69833562T2 (de) Nanoelektrodenanordnung
US6048692A (en) Sensors for electrically sensing binding events for supported molecular receptors
DE10255755B4 (de) Integrierte elektronische Schaltung mit Feldeffekt-Sensoren zum Nachweis von Biomolekülen
DE60221046T2 (de) Nachweis von sondenmolekülen, die auf einen aktiven bereich eines sensors gebunden sind
EP1032836A1 (fr) Dispositif et procede permettant de detecter des substances a analyser
WO2005105308A1 (fr) Supports poreux fonctionnalises pour microreseaux
WO2004001405A1 (fr) Reseau de biocapteurs et procede d'utilisation d'un reseau de biocapteurs
DE19740263A1 (de) Kachelungsverfahren zum Bauen eines chemischen Arrays
EP1277055B1 (fr) Biopuce pour l'archivage et l'analyse en laboratoire medical d'un echantillon biologique
DE3513168A1 (de) Biosensor bestehend aus einem halbleiter auf silizium oder kohlenstoffbasis (elektronischer teil) und nukleinbasen (od. anderen biol. monomeren)
EP1385986A2 (fr) Ensemble biopuce
DE10049901A1 (de) Vorrichtung und Verfahren zur elektrisch beschleunigten Immobilisierung und zur Detektion von Molekülen
EP1738172B1 (fr) Procede de fonctionnalisation de puces de biocapteurs
EP1152832B1 (fr) Champ de mesure de detecteur destine au controle du bon fonctionnement d'une micropipette
DE10224567B4 (de) Sensor-Anordnung und Verfahren zum Betreiben einer Sensor-Anordnung
DE10259819B4 (de) Verfahren zur PCR-Amplifikation und Detektion von Nucleotidsequenzen
WO2005001479A1 (fr) Element biodetecteur capacitif et procede de detection d'evenements d'hybridation
EP1573328B1 (fr) Biopuce
WO2003083134A1 (fr) Detecteur permettant une determination qualitative et quantitative d'oligomeres et polymeres (bio)organiques, procede d'analyse associe et procede de production du detecteur
DE10211358B4 (de) Vertikal-Impedanz-Sensor-Anordnung und Verfahren zum Herstellen einer Vertikal-Impedanz-Sensor-Anordnung
WO2003025204A2 (fr) Ensemble biopuce, ensemble capteurs et procede permettant de faire fonctionner un ensemble biopuce
DE10327683A1 (de) Verfahren und Vorrichtung zum quantitativen elektrischen Nachweis von Analyten
DE10156433A1 (de) Verfahren und Vorrichtungen zur elektronischen Bestimmung von Analyten
DE10323858A1 (de) Sensor-Element, Sensor-Array und Verfahren zum Herstellen eines Sensor-Elements

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20031112

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050805